Mounjaro® /Tirzepatide

Posted by: Admin-Sharnbrook - Posted on:

You may have heard that Tirzepatide, which you may also know as Mounjaro® or ‘the weight loss drug’, is now available from primary care. However, strict entry criteria have been set by NHS England to allow safe entry of this repurposed medicine into the health system.

The eligibility criteria are as follows: 

A BMI of 35 kg/m2 or higher (32.5 kg/m2 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds) and at least four of these additional conditions, which will already have been diagnosed by your GP or another medical professional:

  • Hypertension 
  • Dyslipidaemia 
  • Obstructive sleep apnoea
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Type 2 diabetes mellitus 

For patients who meet the eligibility criteria above, in discussion with your GP, a decision will be made whether or not Tirzepatide is the best treatment for you. If it is agreed that Tirzepatide is the right choice you will also be required to fully engage with a behavioural support programe that your GP will refer you to.